Website stats for Dupixent - dupixent.com
Important Safety Information and Indications Do not use if you are allergic to dupilumab or to any of the ingredients in DUPIXENT. Before using DUPIXENT, tell your healthcare provider about all your medical conditions, including if you: have eye problems have a parasitic (helminth) infection are scheduled to receive any vaccinations. You should not receive a “live vaccine” if you ar...
dupixent.com was registered 9 years 4 months ago. It has a alexa rank of #360,078 in the world. It is a domain having .com extension. It is estimated worth of $ 25,920.00 and have a daily income of around $ 48.00. As no active threats were reported recently, dupixent.com is SAFE to browse.
Traffic Report
| Daily Unique Visitors: | 4,261 |
| Daily Pageviews: | 17,044 |
Estimated Valuation
| Income Per Day: | $ 48.00 |
| Estimated Worth: | $ 25,920.00 |
Search Engine Indexes
| Google Indexed Pages: | Not Applicable |
| Yahoo Indexed Pages: | Not Applicable |
| Bing Indexed Pages: | Not Applicable |
Search Engine Backlinks
| Google Backlinks: | Not Applicable |
| Bing Backlinks: | Not Applicable |
| Alexa BackLinks: | Not Applicable |
Safety Information
| Google Safe Browsing: | No Risk Issues |
| Siteadvisor Rating: | Not Applicable |
| WOT Trustworthiness: |
 Very Poor
|
| WOT Privacy: |
Very Poor
|
| WOT Child Safety: |
Very Poor
|
Website Ranks & Scores
| Alexa Rank: | 360,078 |
| PageSpeed Score: | 89 ON 100 |
| Domain Authority: |
49 ON 100 
|
| Bounce Rate: | Not Applicable |
| Time On Site: | Not Applicable |
Web Server Information
Hosted IP Address:
40.79.44.181
Hosted Country:
US
Location Latitude:
36.6676Location Longitude:
-78.3875Traffic Classification
| Total Traffic: | 406.12K |
| Direct Traffic: | 15.70% |
| Referral Traffic: | 3.67% |
| Search Traffic: | 65.05% |
| Social Traffic: | 0.71% |
| Mail Traffic: | 0% |
| Display Traffic: | 14.88% |
Search Engine Results For dupixent.com
Take Action With DUPIXENT® (dupilumab)
DUPIXENT is a prescription medicine used: to treat people aged 6 years and older with moderate-to-severe atopic dermatitis (eczema) that is not well controlled ...
DUPIXENT MyWay® Copay Card | DUPIXENT® (dupilumab)
With the DUPIXENT MyWay Copay Card , eligible, commercially insured ...
DUPIXENT® Injection Instructions & Support | DUPIXENT ...
DUPIXENT is available as a single-dose pre-filled syringe (200 mg or 300 mg) ...
DUPIXENT MyWay® Support for Patients | DUPIXENT® (dupilumab)
DUPIXENT MyWay® is a patient support program designed to assist with ...
DUPIXENT® (dupilumab) for Moderate-to-Severe Eczema that is ...
DUPIXENT is a prescription medicine used to treat people aged 6 years and ...
How DUPIXENT® (dupilumab) Works
DUPIXENT is a prescription medicine used to treat people aged 6 years and ...
Pricing and Insurance | DUPIXENT® (dupilumab)
DUPIXENT helps prevent severe asthma attacks (exacerbations) and can ...
DUPIXENT® (dupilumab) in Moderate-to-Severe Asthma
DUPIXENT is a prescription medicine used with other asthma medicines for the ...
Welcome - Dupixent
Uncontrolled Moderate-to-Severe ( Eczema) ATOPIC DERMATITIS (Ages 6 +)
DUPIXENT® (dupilumab) in Moderate-to-Severe Asthma | HCP
DUPIXENT® (dupilumab) is an add-on maintenance therapy for your moderate- to-severe asthma patients aged 12+ with an eosinophilic phenotype or with oral ...
DUPIXENT® (dupilumab) Injection by Regeneron
Atopic Dermatitis: DUPIXENT is indicated for the treatment of patients aged 6 years and older with moderate-to-severe atopic dermatitis whose disease is not ...
lääkevalmisteiden pakkausselosteet - DUPIXENT - Lääkeinfo.fi
DUPIXENT injektioneste, liuos, esitäytetty kynä 200 mg (DUPIXENT, SANOFI); DUPIXENT injektioneste, liuos, esitäytetty kynä 300 mg (DUPIXENT, SANOFI) ...
Dupixent - Terveyskirjasto
Dupixent. Markkinoija. SANOFI. Vaikuttava aine. dupilumabi. Käyttötarkoitus. Lääkettä käytetään aikuisten ja nuorten atooppiseen ihottumaan, ...
DUPIXENT® (dupilumab) - FDA
DUPIXENT is administered by subcutaneous injection. 2.1. Atopic Dermatitis. The recommended dose of DUPIXENT for adult patients is an initial dose of 600 mg ( ...
FDA approves Dupixent® (dupilumab) as first biologic medicine for ...
The U.S. Food and Drug Administration (FDA) approved Dupixent® (dupilumab) for children aged 6 to 11 years with moderate-to-severe atopic dermatitis.
Dupixent for Atopic Dermatitis FAQs | Treatment for Atopic Dermatitis
What is Dupixent? Dupixent is the first biologic medication approved by the FDA for adults and children aged 6+ years with moderate to severe atopic dermatitis.
Atopic Dermatitis
Upcoming events helping to transform atopic dermatitis for Dermatologists using DUPIXENT.
FDA approves new Dupixent® (dupilumab) pre-filled pen designed ...
19 Jun 2020 ... Dupixent is approved in the U.S. to treat patients aged 6 years and older with moderate-to-severe atopic dermatitis that is not well controlled with ...
DUPIXENT 200 MG INJEKTIONESTE ESITÄYTETTY RUISKU 2 X 1 ...
Lääkettä käytetään aikuisten ja nuorten atooppiseen ihottumaan, kun paikallishoito ei riitä. Lisäksi sitä voidaan käyttää aikuisten ja n.
Eucrisa vs. Dupixent Treatment for Eczema (Atopic Dermatitis ...
Eucrisa (crisaborole) ointment and Dupixent (dupilumab) injection are indicated for topical treatment of atopic dermatitis (eczema) in patients 2 years of age and ...
Page Resources Breakdown
Homepage Links Analysis
Website Inpage Analysis
| H1 Headings: | 2 | H2 Headings: | 7 |
| H3 Headings: | Not Applicable | H4 Headings: | 1 |
| H5 Headings: | Not Applicable | H6 Headings: | Not Applicable |
| Total IFRAMEs: | 1 | Total Images: | 5 |
| Google Adsense: | Not Applicable | Google Analytics: | Not Applicable |
Two Phrase Analysis
| Words | Occurrences | Density | Possible Spam |
|---|---|---|---|
| healthcare provider | 13 | 0.781 % | No |
| is not | 12 | 0.721 % | No |
| your healthcare | 11 | 0.661 % | No |
| DUPIXENT is | 10 | 0.601 % | No |
| if you | 9 | 0.541 % | No |
| It is | 6 | 0.36 % | No |
| not known | 6 | 0.36 % | No |
| of age | 5 | 0.3 % | No |
| you have | 5 | 0.3 % | No |
| side effects | 5 | 0.3 % | No |
| years of | 5 | 0.3 % | No |
| 12 years | 5 | 0.3 % | No |
| 300mg Dose | 4 | 0.24 % | No |
| Uncontrolled ModeratetoSevere | 4 | 0.24 % | No |
| is a | 4 | 0.24 % | No |
| you are | 4 | 0.24 % | No |
| Addon Maintenance | 4 | 0.24 % | No |
| Tell your | 4 | 0.24 % | No |
| Sanofi US | 4 | 0.24 % | No |
| Maintenance Treatment | 4 | 0.24 % | No |
Four Phrase Analysis
| Words | Occurrences | Density | Possible Spam |
|---|---|---|---|
| It is not known | 6 | 0.36 % | No |
| Maintenance Treatment for Uncontrolled | 4 | 0.24 % | No |
| Tell your healthcare provider | 4 | 0.24 % | No |
| Addon Maintenance Treatment for | 4 | 0.24 % | No |
| not known if DUPIXENT | 3 | 0.18 % | No |
| is not known if | 3 | 0.18 % | No |
| is safe and effective | 3 | 0.18 % | No |
| DUPIXENT is safe and | 3 | 0.18 % | No |
| known if DUPIXENT is | 3 | 0.18 % | No |
| if DUPIXENT is safe | 3 | 0.18 % | No |
| used to treat sudden | 3 | 0.18 % | No |
| tell your healthcare provider | 3 | 0.18 % | No |
| effective in children with | 3 | 0.18 % | No |
| safe and effective in | 3 | 0.18 % | No |
| DUPIXENT is not used | 3 | 0.18 % | No |
| rhinosinusitis with nasal polyposis | 3 | 0.18 % | No |
| your healthcare provider if | 3 | 0.18 % | No |
| to treat sudden breathing | 3 | 0.18 % | No |
| healthcare provider if you | 3 | 0.18 % | No |
| treat sudden breathing problems | 3 | 0.18 % | No |
Websites Hosted on Same IP (i.e. 40.79.44.181)
Medley - Saúde é a gente que faz
Precisão, controle, transparência e a incansável dedicação em cuidar de cada detalhe. É isso o que você encontra em cada caixinha de Medley.
790,265 
$ 1,680.00
Osteoarthritis Knee Pain Relief Treatment | Synvisc-One® Official Site
Synvisc-One (hylan G-F 20) is the only treatment that can give you up to six months of osteoarthritis (OA) knee pain relief with a single injection.
2,693,984 $ 480.00
Enterogermina - el probiótico número 1 recomendado por pediatras
Tu solución eficaz, confiable y segura siempre a la mano, para tratar la diarrea de tus hijos. Es tu aliado de cabecera contra la diarrea.
3,994,046 $ 240.00
Insulin Glargine | Lantus® (insulin glargine injection) 100...
Lantus (insulin glargine) is the most prescribed long acting insulin. Millions of people every day count on Lantus to help them manage their A1C and control their blood sugar.
1,040,595 $ 1,200.00
Dorflex - Remédio para Dor de Cabeça e Dor Muscular
Confira os benefícios e a composição de Dorflex, um relaxante muscular e analgésico que serve para o alívio de dores musculares e dor de cabeça. Acesse!
1,070,259 $ 1,200.00
HTTP Header Analysis
Status-Code: 200
Status: 200 OK
Cache-Control: private
Content-Type: text/html; charset=utf-8
Server: Microsoft-IIS/8.5
X-AspNetMvc-Version: 5.2
X-AspNet-Version: 4.0.30319
Request-Context: appId=cid-v1:352d0284-ac30-451f-a41e-2b6fd36930be
Access-Control-Allow-Origin: *
Access-Control-Allow-Headers: Origin, X-Requested-With, Content-Type, Accept
Access-Control-Allow-Methods: GET, POST, PUT, DELETE, OPTIONS
X-Frame-Options: SAMEORIGIN
Vary: Accept-Encoding
Content-Encoding: gzip
Date: Tue, 09 Mar 2021 19:07:44 GMT
Content-Length: 12730
Connection: keep-alive
Domain Information
| Domain Registrar: |
CSC Corporate Domains, Inc.
|
|---|---|
| Registration Date: | 2015-05-29 9 years 4 months 2 days ago |
| Last Modified: | 2020-05-25 4 years 4 months 6 days ago |
Domain Nameserver Information
| Host | IP Address | Country | |
|---|---|---|---|
| ns1.sanofi-synthelabo.com | |
205.251.198.127 | United States |
| ns2.sanofi-synthelabo.com | |
205.251.196.144 | United States |
| ns3.sanofi-synthelabo.com | |
205.251.193.224 | United States |
| ns4.sanofi-synthelabo.com | |
205.251.194.58 | United States |
DNS Record Analysis
| Host | Type | TTL | Extra |
|---|---|---|---|
| dupixent.com | A | 896 |
IP: 40.79.44.181 |
| dupixent.com | NS | 900 |
Target: ns2.sanofi-synthelabo.com |
| dupixent.com | NS | 900 |
Target: ns3.sanofi-synthelabo.com |
| dupixent.com | NS | 900 |
Target: ns4.sanofi-synthelabo.com |
| dupixent.com | NS | 900 |
Target: ns1.sanofi-synthelabo.com |
| dupixent.com | SOA | 900 |
MNAME: ns1.sanofi-synthelabo.com RNAME: gtly-domtech.sanofi.com Serial: 2016030804 Refresh: 28800 Retry: 14400 Expire: 3600000 |
| dupixent.com | MX | 900 |
Priority: 10 Target: rmx.s4.exacttarget.com |
| dupixent.com | TXT | 900 |
TXT: spf2.0/pra include:cust-senderid.exacttarget.com -all |
| dupixent.com | TXT | 900 |
TXT: v=spf1 include:cust-spf.exacttarget.com -all |
| dupixent.com | TXT | 900 |
TXT: facebook-domain-verification=964rhj7euqn 74m1sba94j7ef906hcx |
| dupixent.com | TXT | 900 |
TXT: google-site-verification=BTosYzJICtnNF0s AIBMJ8t4raIaJXc0HONZh0vd2bxA |
Top Organic Keyword
| 1. | dupixent |
| 2. | dupilumab |
| 3. | dupixent my way |
| 4. | dupixent injection |
| 5. | dupixent cost |
Top Paid Keyword
| 1. | dupixent |
| 2. | dupixent cost |
| 3. | dupilumab |
| 4. | dupixent side effects |
| 5. | dupixent coupons |
Top Referral Site
| 1. | healthandconditions.com |
| 2. | justfood4thought.com |
| 3. | askfest.com |
| 4. | zestious.com |
| 5. | sanofigenzyme.com |
Top Destination Site
| 1. | healthgrades.com |
| 2. | dupixenthcp.com |
| 3. | sanofi.us |
| 4. | regeneron.com |
| 5. | calendar.google.com |
Full WHOIS Lookup
Registry Domain ID:
1933538903_DOMAIN_COM-VRSN
Registrar WHOIS Server:
whois.corporatedomains.com
Registrar URL:
http://cscdbs.com
Updated Date: 2020-05-25T05:23:45Z
Creation
Date: 2015-05-29T11:47:44Z
Registry Expiry Date:
2021-05-29T11:47:44Z
Registrar: CSC Corporate Domains,
Inc.
Registrar IANA ID: 299
Registrar Abuse Contact Email:
[email protected]
Registrar Abuse Contact Phone:
8887802723
Domain Status: clientTransferProhibited
https://icann.org/epp#clientTransferProhibited
Name Server:
NS1.SANOFI-SYNTHELABO.COM
Name Server:
NS2.SANOFI-SYNTHELABO.COM
Name Server:
NS3.SANOFI-SYNTHELABO.COM
Name Server:
NS4.SANOFI-SYNTHELABO.COM
DNSSEC: unsigned
URL of the ICANN
Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>>
Last update of whois database: 2021-03-09T19:07:13Z
Similarly Ranked Websites
Secure the Enterprise of Things with Armis.
Armis is the first agentless, enterprise-class security platform to address the new threat landscape of unmanaged and IoT devices. See how we can protect your business.
360,082 $ 25,920.00
400 Bad Request
This is the home page for Samaritan's Purse, an international, nondenominational, evangelical Christian disaster relief organization.
360,084 $ 25,920.00
Educational Advisory Company | ERBlearn.org
With more than 90 years of academic assessment expertise, we are an Educational Advisory Company trusted by educators around the world to deliver objective tools that provide...
360,094 $ 25,920.00
Учреждение образования Белорусский государственный университет...
БГУФК
360,095 $ 25,920.00